When people think about new inventions, 95% of them immediately begin thinking about tech inventions, but what about medical inventions that save lives?
Merck recently launched a video that asked Americans what invention they are waiting for. Take a look.
Did you know 68% of Americans cannot name a single scientist working to invent medicine?
Merck has been working for over a century on medicines and vaccines that save lives. Visit their site on Inventing for Life where you can see a timeline of Merck’s work as well as meet some of its scientists, and see some of its impact on the world’s most challenging diseases.
I’m happy to share this video today as I know how important their work is on maternal health with Merck for Mothers.
Earlier this month I wrote about Uganda’s move to use misoprostol for women who experience postpartum hemorrhage (PPH) during childbirth or immediately after delivery. PPH is the leading cause of maternal mortality for women around the world. 800 women die every day from complications during pregnancy and delivery; that is two mothers a minute.
Misoprostol, it has been found, is effective because it will stop a woman’s bleeding, can be taken in pill form and can be stored at hotter temperatures. Oxytocin, which is the gold standard for stopping PPH must be stored in cold temperatures to be effective. However, in low-resource settings electricity can be touch and go or altogether nonexistent.
Last year Merck announced that they have partnered with the World Health Organization as well as Ferring Pharmaceuticals to test the efficacy in clinical trials of using carbetocin, another medication that can stop PPH, but can be stored in hot and tropical environments.
The clinical trials began this year in 12 countries that included 29,000 women. Through its Merck for Mothers initiative, Merck has partnered with organizations in the United States and abroad to reduce maternal mortality around the world.
Continue reading Merck and WHO Partner to Curb Postpartum Hemorrhage Deaths